Abstract:Cardiovascular complications are the leading cause of death in diabetic patients. Among them, diabetic cardiomyopathy (DCM) is a type of specific cardiomyopathy excluding myocardial damage caused by hypertension and coronary heart disease. It is characterized by abnormal metabolism of cardiomyocytes and gradual decline of cardiac function. The clinical manifestations of DCM are impaired diastolic function in early stage and impaired systolic function in late stage. Eventually it developed into heart failure. Mitochondria are the main organelles that provide energy in cardiomyocytes. Mitochondrial dynamics refers to the dynamic process of mitochondrial fusion and fission, which is an important approach for mitochondrial quality control. Mitochondrial dynamics plays a crucial role in maintaining mitochondrial homeostasis and cardiac function. The proteins that regulate mitochondrial fission are mainly Drp1 and its receptors, Fis1, MFF, MiD49 and MiD51. The protein that performs mitochondrial outer membrane fusion is Mfn1/2, and the inner membrane fusion protein is Opa1. This paper reviews recent progress on mitochondrial dynamics in DCM. The main contents are as follows: mitochondrial dynamics imbalance in both type 1 and 2 DCM is manifested as increased fission and inhibited fusion. The molecular mechanism of the former is mainly associated with up-regulated Drp1 and down-regulated Opa1, while the molecular mechanism of the latter is mainly associated with up-regulated Drp1 and down-regulated Mfn1/2. Increased mitochondrial fission and inhibited fusion can lead to mitochondrial dysfunction and promote the development of DCM. The active ingredients of the traditional Chinese medicine such as punicalagin, paeonol and endogenous substance melatonin can improve mitochondrial function and alleviate the symptoms of DCM by inhibiting mitochondrial fission or promoting mitochondrial fusion. This article is helpful to further understand the role and mechanism of mitochondrial dynamics in DCM, and provide new treatment methods and intervention strategies for clinical DCM patients based on mitochondrial dynamics.

Molecular regulation of mitochondrial dynamics in cardiac disease

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

The role of mitochondrial dynamics in disease

Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease

Novel insights into the involvement of mitochondrial fission/fusion in heart failure: From molecular mechanisms to targeted therapies

Mitochondrial dynamics and cell death in heart failure

The Role of Mitochondrial Fusion and Fission in the Process of Cardiac Oxidative Stress.

Mitochondrial dynamics and inter-mitochondrial communication in the heart

[Role of mitochondrial dynamics in diabetic cardiomyopathy and regulatory mechanisms]

Mitochondrial Dynamics, Diabetes, and Cardiovascular Disease

Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury

Role of GTPase-Dependent Mitochondrial Dynamins in Heart Diseases

Current Understanding of the Pivotal Role of Mitochondrial Dynamics in Cardiovascular Diseases and Senescence

Mitochondrial dynamics in health and disease: mechanisms and potential targets

Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics

Drp1-dependent mitochondrial fission in cardiovascular disease

The role of mitochondrial dynamics in cardiovascular diseases

Dysregulation of Mfn2 and Drp-1 proteins in heart failure

Modulating mitochondrial dynamics ameliorates left ventricular dysfunction by suppressing diverse cell death pathways after diabetic cardiomyopathy

Roles of mitochondrial dynamics and mitophagy in diabetic myocardial microvascular injury

Mitochondrial dynamics in neurological diseases: a narrative review